Your Heart and ACTN2

Because the alpha-actinin-2 protein is used in both your skeletal muscles and your heart, a diagnosis of an ACTN2-related disease often includes a focus on cardiac health ^[1]. However, it is important to know that the heart is not always affected. In several reported cohorts of patients with ACTN2-related skeletal myopathy, significant heart issues were actually uncommon ^[2][3]. A diagnosis of skeletal muscle weakness does not mean that heart failure is inevitable, but because the evidence comes from small cohorts, careful surveillance is still required.

When to Seek Urgent Care

Because ACTN2 variants can be linked to heart rhythm issues and cardiomyopathy, you should have a clear action plan. Seek urgent emergency medical attention (such as calling 911 or going to the emergency room) if you experience:

• Fainting, near-fainting, or unexpected collapse.
• Sudden, severe chest pain.
• Sustained or highly symptomatic palpitations (a rapidly racing, fluttering, or pounding heart), especially if accompanied by dizziness.
• Sudden severe breathlessness, blue lips, or acute respiratory distress.

For less urgent signs—such as new swelling in your legs, gradually worsening exercise tolerance, or shortness of breath when lying flat—contact your cardiologist or neuromuscular team promptly for an evaluation.

Types of Cardiomyopathy

When the heart is involved, it usually takes the form of a cardiomyopathy—a disease that changes the heart muscle’s structure or function. Reported phenotypes in patients with ACTN2 variants include:

• Hypertrophic Cardiomyopathy (HCM): The walls of the heart become abnormally thick. This thickening commonly causes impaired relaxation and filling of the heart, and sometimes blocks blood flow out of the heart (outflow obstruction), even if the heart’s pumping action initially appears normal ^[4][5].
• Dilated Cardiomyopathy (DCM): The heart muscle becomes thin and stretched (dilated), causing the heart chambers to enlarge and weakening its ability to pump ^[6][5].
• Restrictive Cardiomyopathy (RCM): The heart muscle becomes stiff and less flexible, which prevents the heart from filling with blood properly between beats ^[5].
• Left-Ventricular Non-Compaction (LVNC): A condition where the heart muscle has a “spongy” appearance rather than being smooth and firm ^[6].

Heart Rhythm and Arrhythmias

In addition to structural changes, some ACTN2 variants can affect the heart’s electrical system, leading to arrhythmias (irregular heartbeats) ^[1].

Specific electrical issues reported in the literature include:

• Atrial Fibrillation (AFib): A fast, irregular rhythm in the upper chambers of the heart ^[4][7].
• Prolonged QTc Interval: A change in the time it takes for the heart’s electrical system to “reset” after a beat. This has been noted in some affected families ^[4].

The Importance of Baseline Screening

Because symptoms of heart disease can be subtle, a baseline cardiac evaluation is commonly considered standard care for anyone confirmed to carry a pathogenic or likely pathogenic ACTN2 variant ^[4][2]. (Note: If you have a Variant of Uncertain Significance, testing and follow-up will depend on your specific phenotype, family history, and specialist guidance, rather than the variant alone.)

This initial evaluation typically includes:

1. Electrocardiogram (ECG or EKG): A quick test that records the electrical activity of your heart to look for rhythm issues or signs of thickened muscle ^[4].
2. Echocardiogram (Echo): An ultrasound of the heart that allows doctors to see the heart’s structure and measure how well it is pumping ^[4][6].

If these tests are normal, your doctor will likely recommend periodic follow-up screenings based on your age and clinical picture. A normal baseline test does not eliminate future risk, so staying proactive with individualized monitoring ensures that any changes can be caught and managed early.